TECH vs XPEL · P/E 65, rev $1.22B vs P/E 24, rev $420.4M
Bio-Techne Corp (TECH) versus Xpel Inc (XPEL) — a side-by-side from cached financials, not a winner call.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Xpel Inc (XPEL) is a auto parts company listed on NASDAQ.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Latest reported XPEL revenue for 2024-12-31 was $420.4M. Net income was $45.5M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. XPEL currently screens at market cap $1.25B and trailing P/E 23.7.
TECH currently screens at market cap $8.49B and trailing P/E 65.2. XPEL currently screens at market cap $1.25B and trailing P/E 23.7.
Not investment advice. Open the TECH and XPEL stock pages for the full models.
Not investment advice.